Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Funds will be put towards upgrading facilities and working capital
Thursday 13 Apr 2017 Author: Lisa-Marie Janes

Abzena (ABZA:AIM) has raised £25m to fund several growth initiatives, which include upgrading its US biomanufacturing facilities so it can supply more products.

Approximately £11m will be spent on its San Diego facility while £6m will be earmarked to enhance its biology and chemistry offering in the UK and US. The remaining £8m will be used for working capital.



‹ Previous2017-04-13Next ›